Skip to main contentueyrxxbvyuudbcrz

Institute for the Study of Aging, Inc.

Profile

Last Updated: 2016-01-31

At A Glance

Institute for the Study of Aging, Inc.

57 W. 57th St., No. 904

New York City, NY United States 10019-2802

Telephone: (212) 901-8000

URL: www.alzdiscovery.org

Type of Grantmaker

Independent foundation

Additional Descriptor

  • Celebrity: Business; Politics

Financial Data

(yr. ended 2013-12-31)

Assets: $5,126,286

Total giving: $35,000

EIN

134024149

BRIDGE Number

8046169790

Background

Established in 1998 in NY

Purpose and Activities

The Institute is a biomedical venture philanthropy whose mission is to catalyze and fund the discovery and development of new therapies to prevent and treat Alzheimer's disease.

Program Area(s)

The grantmaker has identified the following area(s) of interest:

Academic Drug Development Program

The program funds academic scientists with innovative ideas for proof of concept clinical trials of new approaches to the treatment, prevention and early detection of cognitive aging and Alzheimer's disease.

Academic Drug Discovery Program

The program seeks to create and support innovative drug discovery programs for cognitive aging and Alzheimer's disease in academic medical centers and universities.

Biotechnology Development Program

The program provides early stage biotechnology companies with funding for specific research programs related to cognitive aging and Alzheimer's disease. Grants are provided through two funding vehicles: PRIs and recoverable grants.

Biotechnology Founder's Program

The program invests in new start-up biotechnology companies dedicated to developing novel pharmaceuticals for the treatment of cognitive aging and Alzheimer's disease. The funding is provided through program-related investments (PRIs) that require return on investment based upon scientific and/or business milestones.

Conferences

The institute initiates, sponsors, and co-sponsors conferences to catalyze and stimulate new ideas and approaches in areas of interest to the Institute, bringing together outstanding physicians, scientists, and policy makers from the U.S. and from the international community.

Program-Related Investment

The foundation has made PRIs to medical research organizations to conduct Alzheimer's disease research.

Fields of Interest

Subjects
  • Alzheimer's disease
  • Biotechnology
  • Brain and nervous system disorders
  • Diseases and conditions
  • Health
  • Higher education
  • Hospital care
  • Medical education
  • Medical specialties
  • Pharmacology
Population Groups
  • Adults
  • People with disabilities
  • People with psychosocial disabilities
  • Seniors

Financial Data

Year ended 2013-12-31

Assets: $5,126,286 (market value)

Gifts received: $3,390,106

Expenditures: $3,552,146

Total giving: $35,000

Qualifying distributions: $3,335,914

Giving activities include:

$35,000 for 1 grant